What is the EV/EBITDA ratio for INmune Bio, Inc. (INMB)?

The EV/EBITDA ratio for INMB stock is N/A.

What is the estimated TTM average EV/EBITDA ratio for INmune Bio, Inc. (INMB)?

The estimated TTM average EV/EBITDA ratio for INMB stock is 29.85x.

INmune Bio (INMB) EV/EBITDA: History & Chart

Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/EBITDA ratio is N/A as of 2026-10-06T16:57:11.539Z.

Stored calculation inputs

Calculation as of: 2026-10-06T16:57:11.539Z.

Quote observation: 2026-10-06T16:55:00.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 50,511,990
Total debt · period ending 2026-06-30: 1,405,000
Cash · period ending 2026-06-30: 18,411,000
TTM operating EBITDA · period ending 2026-06-30: -19,987,000

FMP input reference: 8c49465b29cefd47847e7fc901c6d20b09f101de13d3ea96f762810498d8f388

EV/Sales|P/E Ratio|EBITDA|All Metrics

INMB EV/EBITDA Ratio Metrics

EV/EBITDA RATIO

N/A

EV/EBITDA RATIO AVG TTM

29.85x

EV/EBITDA RATIO AVG 3Y

N/A

EV/EBITDA RATIO AVG 5Y

N/A

EV/EBITDA RATIO AVG 10Y

N/A

EV/EBITDA RATIO AVG 15Y

N/A

EV/EBITDA RATIO AVG 20Y

N/A

CURRENT VS TTM AVG

N/A

CURRENT VS 3Y AVG

N/A

CURRENT VS 5Y AVG

N/A

CURRENT VS 10Y AVG

N/A

CURRENT VS 15Y AVG

N/A

CURRENT VS 20Y AVG

N/A

INMB Competitors' EV/EBITDA Ratio

INMB

INmune Bio, Inc.

Current

Market Cap

$50.51M

EV/EBITDA Ratio

N/A

TTM Avg

29.85x

3Y Avg

N/A

5Y Avg

N/A

CLNN

Clene Inc.

vs INMB

Market Cap

$50.54M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ELOX

Eloxx Pharmaceuticals, Inc.

vs INMB

Market Cap

$51.54M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CELU

Celularity Inc.

vs INMB

Market Cap

$50.80M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

APLM

Apollomics, Inc.

vs INMB

Market Cap

$50.38M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

DWTX

Dogwood Therapeutics, Inc.

vs INMB

Market Cap

$52.46M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MBOT

Microbot Medical Inc.

vs INMB

Market Cap

$50.08M

EV/EBITDA Ratio

N/A

TTM Avg

310.55x

3Y Avg

191.07x

5Y Avg

171.86x

COCH

Envoy Medical, Inc.

vs INMB

Market Cap

$51.33M

EV/EBITDA Ratio

N/A

TTM Avg

335.70x

3Y Avg

335.70x

5Y Avg

335.70x

RANI

Rani Therapeutics Holdings, Inc.

vs INMB

Market Cap

$51.38M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

EXOZ

eXoZymes, Inc.

vs INMB

Market Cap

$51.42M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EV/EBITDA RATIO	TTM	3Y	5Y
INmune Bio, Inc. (INMB)	$50.51M	N/A	29.85x	N/A	N/A
Clene Inc. (CLNN)vs ›	$50.54M	N/A	N/A	N/A	N/A
Eloxx Pharmaceuticals, Inc. (ELOX)vs ›	$51.54M	N/A	N/A	N/A	N/A
Celularity Inc. (CELU)vs ›	$50.80M	N/A	N/A	N/A	N/A
Apollomics, Inc. (APLM)vs ›	$50.38M	N/A	N/A	N/A	N/A
Dogwood Therapeutics, Inc. (DWTX)vs ›	$52.46M	N/A	N/A	N/A	N/A
Microbot Medical Inc. (MBOT)vs ›	$50.08M	N/A	310.55x	191.07x	171.86x
Envoy Medical, Inc. (COCH)vs ›	$51.33M	N/A	335.70x	335.70x	335.70x
Rani Therapeutics Holdings, Inc. (RANI)vs ›	$51.38M	N/A	N/A	N/A	N/A
eXoZymes, Inc. (EXOZ)vs ›	$51.42M	N/A	N/A	N/A	N/A

EV/EBITDA Ratio Formula & Definition

EV/EBITDA = Enterprise Value / EBITDA (TTM)

Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

EV/EBITDA Ratio FAQ

What is the EV/EBITDA ratio for INmune Bio, Inc. (INMB)?: The EV/EBITDA ratio for INMB stock is N/A.
What is the estimated TTM average EV/EBITDA ratio for INmune Bio, Inc. (INMB)?: The estimated TTM average EV/EBITDA ratio for INMB stock is 29.85x.

INMB EV/EBITDA Ratio History

DATE	EV/EBITDA RATIO
2020-03-10	21.86x
2020-03-09	21.51x
2020-03-06	22.69x
2020-03-05	23.95x
2020-03-04	23.25x
2020-03-03	23.18x
2020-03-02	23.60x
2020-02-28	26.46x
2020-02-27	27.37x
2020-02-26	27.79x
2020-02-25	28.62x
2020-02-24	30.23x
2020-02-21	31.73x
2020-02-20	32.25x
2020-02-19	30.76x
2020-02-18	31.00x
2020-02-14	30.86x
2020-02-13	31.42x
2020-02-12	30.58x
2020-02-11	29.46x
2020-02-10	30.75x
2020-02-07	30.13x
2020-02-06	30.42x
2020-02-05	29.53x
2020-02-04	28.70x
2020-02-03	28.49x
2020-01-31	29.74x
2020-01-30	28.69x
2020-01-29	29.67x
2020-01-28	31.18x
2020-01-27	28.97x
2020-01-24	30.20x
2020-01-23	29.88x
2020-01-22	31.98x
2020-01-21	34.42x
2020-01-17	34.84x
2020-01-16	34.98x
2020-01-15	34.07x
2020-01-14	34.92x
2020-01-13	35.16x
2020-01-10	35.64x
2020-01-09	35.37x
2020-01-08	34.91x
2020-01-07	36.36x
2020-01-06	37.20x
2020-01-03	35.12x
2020-01-02	38.28x
2019-12-31	35.81x
2019-12-30	32.45x
2019-12-27	32.67x
2019-12-26	32.95x
2019-12-24	33.79x
2019-12-23	35.53x
2019-12-20	37.91x
2019-12-19	36.51x
2019-12-18	35.26x
2019-12-17	35.26x
2019-12-16	31.05x
2019-12-13	29.74x
2019-12-12	28.14x
2019-12-11	28.14x
2019-12-10	28.65x
2019-12-09	29.60x
2019-12-06	31.63x
2019-12-05	31.69x
2019-12-04	30.58x
2019-12-03	29.74x
2019-12-02	29.18x
2019-11-29	29.32x
2019-11-27	28.72x
2019-11-26	25.41x
2019-11-25	23.46x
2019-11-22	22.59x
2019-11-21	23.25x
2019-11-20	25.07x
2019-11-19	26.53x
2019-11-18	25.39x
2019-11-15	26.08x
2019-11-14	25.41x
2019-11-13	26.74x
2019-11-12	26.39x
2019-11-11	27.30x
2019-11-08	23.80x
2019-11-07	24.86x
2019-11-06	24.79x
2019-11-05	26.04x
2019-11-04	26.20x
2019-11-01	27.16x
2019-10-31	26.36x
2019-10-30	29.20x
2019-10-29	25.58x
2019-10-28	26.57x
2019-10-25	26.30x
2019-10-24	26.24x
2019-10-23	26.50x
2019-10-22	27.62x
2019-10-21	26.63x
2019-10-18	22.68x
2019-10-17	21.83x
2019-10-16	18.80x
2019-10-15	17.48x
2019-10-14	19.72x
2019-10-11	20.86x
2019-10-10	21.30x
2019-10-09	20.91x
2019-10-08	24.99x
2019-10-07	27.16x
2019-10-04	27.62x
2019-10-03	28.15x
2019-10-02	30.25x
2019-10-01	30.71x
2019-09-30	32.89x
2019-09-27	31.90x
2019-09-26	32.03x
2019-09-25	30.91x
2019-09-24	31.18x
2019-09-23	30.58x
2019-09-20	31.83x
2019-09-19	32.69x
2019-09-18	32.95x
2019-09-17	34.20x
2019-09-16	33.55x
2019-09-13	33.68x
2019-09-12	34.80x
2019-09-11	34.47x
2019-09-10	34.53x
2019-09-09	35.78x
2019-09-06	35.59x
2019-09-05	35.45x
2019-09-04	36.38x
2019-09-03	33.41x
2019-08-30	33.55x
2019-08-29	35.06x
2019-08-28	36.05x
2019-08-27	33.56x
2019-08-26	33.86x
2019-08-23	33.74x
2019-08-22	33.61x
2019-08-21	30.32x
2019-08-20	33.15x
2019-08-19	31.70x
2019-08-16	29.09x
2019-08-15	32.82x
2019-08-14	32.23x
2019-08-13	34.20x
2019-08-12	34.27x
2019-03-29	381739.25x
2019-03-28	386638.38x
2019-03-27	389087.94x
2019-03-26	389087.94x
2019-03-25	394913.00x
2019-03-22	388842.99x
2019-03-21	385462.59x
2019-03-20	384678.73x
2019-03-19	386638.38x
2019-03-18	375860.30x
2019-03-15	344015.98x
2019-03-14	379289.69x
2019-03-13	364592.31x
2019-03-12	365082.22x
2019-03-11	364592.31x
2019-03-08	367036.97x
2019-03-07	367041.87x
2019-03-06	364592.31x
2019-03-05	368511.61x
2019-03-04	367041.87x
2019-03-01	379289.69x
2019-02-28	388108.12x
2019-02-27	379289.69x
2019-02-26	387128.29x
2019-02-25	395946.72x
2019-02-22	398886.20x
2019-02-21	384188.82x
2019-02-20	383208.99x
2019-02-19	361162.92x
2019-02-15	352222.02x
2019-02-14	357410.19x
2019-02-13	358713.36x
2019-02-12	374390.56x
2019-02-11	373900.65x
2019-02-08	385051.06x
2019-02-07	367654.26x
2019-02-06	376889.12x
2019-02-05	378349.06x
2019-02-04	388598.03x

Related Metrics

EV/Sales P/E Ratio EBITDA All Metrics

EV/EBITDA Ratio: N/A

INMB EV/EBITDA Ratio Chart

INMB Average EV/EBITDA Ratio Chart

INMB EV/EBITDA Ratio Metrics

INMB Competitors' EV/EBITDA Ratio

EV/EBITDA Ratio Formula & Definition

EV/EBITDA Ratio FAQ

INMB EV/EBITDA Ratio History

Related Metrics